Zhejiang Hisun Pharmaceutical, Ltd. operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zhejiang Hisun Pharmaceutical, Ltd. with three other
companies in this sector in China:
Chongqing Taiji Industry (Group)
sales of 10.69 billion Chinese Renmimbi [US$1.59 billion]
of which 74%
WuXi AppTec Co Ltd
(9.61 billion Chinese Renmimbi [US$1.43 billion]
Huapont-Nutrichem Co Ltd
(10.57 billion Chinese Renmimbi [US$1.58 billion]
of which 65%
was Agricultural Business).
Zhejiang Hisun Pharmaceutical, Ltd. reported sales of 10.09 billion Chinese Renmimbi (US$1.50 billion)
December of 2018.
decrease of 4.6%
versus 2017, when the company's sales were 10.57 billion Chinese Renmimbi.